leisure time -WSS

leisure time

author：hotspot 2025-09-10 05:03:24 - browse：14

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： FDA seeking to stop procedures at two unregulated stem cell clinics

leisure time

WSS

There’s no way to know how good AI health technologies are

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

ER docs worry over extreme heat as a 'mass casualty event'

FDA seeking to stop procedures at two unregulated stem cell clinics

Medicare to cover more brain scans related to Alzheimer’s drugs

focus

leisure time

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

European regulators recommend Amylyx's ALS drug be rejected

Duchenne breakthrough therapy leaves behind pioneering families

There’s no way to know how good AI health technologies are

What does generative AI mean for health care? We asked experts

Wellcome Trust names Røttingen as its new CEO

ChatGPT in medicine: STAT answers readers' burning questions

Akero's treatment for NASH falls short in cirrhosis study

United colonoscopy coverage change 'may cost lives,' doctors say

Johnson & Johnson sues to stop Medicare negotiation

hotspot

A look at other Americans who have crossed into North Korea over the years

US soldier in North Korean custody after crossing DMZ line

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Takeaways from AdvaMed, the largest medical devices conference

A revolution in caring for preterm infants

European regulators consider appeal over Amylyx ALS drug

focus

hotspot

leisure time

Wikipedia